Globotriaosylsphingosine (lyso-GB3) as useful marker for monitoring initial therapeutic outcomes of enzyme replacement therapy for patients with Fabry disease

Authors :: Elena Verrecchia
M Giovinale
Raffaele Manna
Daniela Antuzzi
Alessandra Paolucci
Source :: Molecular Genetics and Metabolism. 117:S118
Publication Year :: 2016
Publisher :: Elsevier BV, 2016.

Subjects :: 0301 basic medicine
medicine.medical_specialty
business.industry
Endocrinology, Diabetes and Metabolism
Urology
Enzyme replacement therapy
030105 genetics & heredity
Lyso gb3
medicine.disease
Biochemistry
Fabry disease
03 medical and health sciences
Endocrinology
Genetics
medicine
business
Molecular Biology

Full Text Access

Tools